Filter your results
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines.Journal of Cancer Research and Clinical Oncology, 2012, 138 (6), pp.907-916. ⟨10.1007/s00432-012-1162-x⟩
Journal articles
istex
inserm-00670441v1
|